Apr 14, 2023 / Presentations

Mandated report: Telehealth in Medicare

Research Areas:

Beneficiaries and Coverage, Medicare Spending and Financing

Apr 13, 2023 / Presentations

Assessing the need for Medicare safety net payments for skilled nursing facilities and home health agencies

Research Areas:

Beneficiaries and Coverage, Medicare Spending and Financing, Post-Acute Care, Quality

Apr 13, 2023 / Presentations

Assessing postsale rebates for prescription drugs in Medicare Part D

Research Areas:

Beneficiaries and Coverage, Drugs, Devices, and Tests, Medicare Spending and Financing

Apr 13, 2023 / Presentations

Mandated report: Evaluation of a prototype design for a post-acute care prospective payment system

Research Areas:

Medicare Spending and Financing, Post-Acute Care

Apr 13, 2023 / Presentations

Aligning fee-for-service payment rates across ambulatory settings

Research Areas:

Ambulatory Care Settings, Medicare Spending and Financing

Apr 13, 2023 / Presentations

Reforming Medicare’s wage index systems

Research Areas:

Hospitals, Medicare Spending and Financing, Regional Issues

Apr 13, 2023 / Presentations

Addressing the high prices of drugs covered under Medicare Part B

Research Areas:

Drugs, Devices, and Tests, Medicare Spending and Financing

Mar 15, 2023 / Reports

March 2023 Report to the Congress: Medicare Payment Policy

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues

Mar 15, 2023 / Chapters

Appendix A: Commissioners’ voting on recommendations (March 2023 Report)

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues

Mar 15, 2023 / Chapters

Chapter 12: The Medicare prescription drug program (Part D): Status report (March 2023 Report)

Research Areas:

Drugs, Devices, and Tests, Quality